Orthofix appoints new president of bone growth therapies business
Click Here to Manage Email Alerts
Key takeaways:
- Orthofix has announced Jason Shallenberger as president of its bone growth therapies.
- The bone growth therapies and spine businesses of Orthofix will be led by separate presidents.
- Changes are effective March 1.
Orthofix Medical Inc. has announced Jason Shallenberger as president of its bone growth therapies business. The company also announced a realignment of its spine business, according to a press release.
Shallenberger, who previously served as vice president of U.S. sales and marketing for the bone growth therapies business of Orthofix, will assume the role of president of its bone growth therapies.
“Jason has led sales and marketing for this successful franchise for a number of years,” Massimo Calafiore, president and CEO of Orthofix, said in the release. “Under his guidance, the sales team has produced quarter-after-quarter of double-digit growth in 2023. I am confident he will do an amazing job as president and continue to contribute greatly to the success of Orthofix,” Calafiore added.
“Since 1986, Orthofix bone growth therapy has helped promote the natural-bone healing process in patients,” Shallenberger said in the release. “I am honored to continue my career with the company in this new role as we continue to innovate and bring new technologies to the market,” he said.
Orthofix also announced the realignment of its spine business unit. Bone growth therapies and spine will now be led by separate presidents, according to the release.
Both changes are effective March 1.
Read more about
Click Here to Manage Email Alerts